Carcinoma of the cervix, endometrium, and ovary: an 11-year review.
Over an 11-year period, 164 patients with genital tract carcinoma were managed at the Austin Hospital, Melbourne. For patients receiving primary treatment at the hospital, the five-year survival rates of patients with carcinoma of the cervix, endometrium, and ovary were 47.8%, 41.6% and 4.3% respectively. Improved results rest upon earlier diagnosis and alternative therapeutic measures, especially for carcinoma of the endometrium and ovary. Routine surveillance after initial therapy may detect asymptomatic metastatic disease when curative treatment is still possible.
D000328:Adult; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000628:therapy*; D011379:Prognosis; D002583:Uterine Cervical Neoplasms / Q000628:therapy*; D014594:Uterine Neoplasms / Q000628:therapy*